<DOC>
	<DOCNO>NCT01049620</DOCNO>
	<brief_summary>It expect RAD001 work gastric cancer inhibit PI3K/AKT/mTOR pathway Hif1A ( hypoxia inducible factor 1 , alpha subunit ) , key player angiogenesis growth tumor like renal cell carcinoma.However , RAD001 alone look enough control gastric cancer . By mechanism , RAD001 show additive synergistic effect combination conventional chemotherapy . In study , XELOX select conventional combination chemotherapy proven active safe gastric cancer . Combination XELOX RAD001 never try treatment cancer patient yet . So , optimal dose first determine phase I study</brief_summary>
	<brief_title>RAD001 Combination With Capecitabine Oxaliplatin ( XELOX ) Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description>For first cohort phase I study , drug capecitabine , oxaliplatin , RAD001 start one two dose ordinary full dose drug single agent .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Histologically cytologically document unresectable metastatic adenocarcinoma stomach gastroesophageal junction No history chemotherapy radiation Age 18 70 year old Estimated life expectancy least 3 month Eastern Cooperative Oncology Group ( ECOG ) performance status 02 Adequate bone marrow function ( white blood cell count &gt; 3,000/uL , absolute neutrophil count &gt; 1,500/uL , Platelets &gt; 100,000/uL , Hgb &gt; 8 g/dL ) Adequate kidney function ( creatinine &lt; 1.5 mg/dL ) Adequate liver function ( bilirubin &lt; 1.5 mg/dL , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) level &lt; 3 time upper normal limit ( 5 time patient liver metastasis ) ) Signed write informed consent Past concurrent history neoplasm gastric adenocarcinoma except curatively treat basal cell carcinoma skin situ carcinoma cervix uteri Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior study treatment start Presence central nervous system metastasis Bowel obstruction Evidence serious gastrointestinal bleeding Peripheral neuropathy ( NCI CTC AE version 3.0 &gt; Grade I ) History significant neurologic psychiatric disorder Pregnant lactate woman , woman childbearing potential employ adequate contraception Other serious illness medical condition Patients know history ischemic heart disease and/or myocardial infarction Known allergy study drug Administration drug show interaction RAD001</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>XELOX</keyword>
	<keyword>RAD001</keyword>
	<keyword>phase 1</keyword>
</DOC>